LifeVantage Corporation

LifeVantage Corporation

LFVN
LifeVantage CorporationUS flagNASDAQ Capital Market
6.40
USD
+0.14
- -
80.74MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
12.98
14.16
13.69
15.04
14.37
14.52
16.08
16.51
15.65
16.01
16.99
16.07
- -
15.63
Basic EPS, GAAP
0.47
0.75
0.51
0.44
0.12
0.41
0.53
0.82
0.92
0.24
0.2
0.24
- -
0.46
Free Cash Flow per Basic Share
0.35
0.65
0.87
0.4
0.4
0.62
1.09
1.11
0.89
0.5
0.3
0.8
- -
0.3
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.03
0.13
0.56
- -
0.18
Book Value per Share
-4.76
-7.35
-8.21
-7.91
-7.71
-7.34
-7.11
-6.62
-6.56
-7.64
-7.83
-8.73
- -
-8.29
Tangible Book Value per Share
2.01
0.13
0.1
0.65
0.96
1.49
1.87
2.3
2.56
2.4
2.72
2.06
- -
2.37
Basic Weighted Avg Shares
16
15
14
14
14
14
14
14
14
13
13
12
- -
12
Sales/Revenue/Turnover
208
214
190
207
199
203
226
233
220
206
213
200
229
195
Operating Margin (%)
5.8
9.09
7.3
6.49
2.23
5.08
4.34
6.64
8
3.67
2
2.16
5.34
3.37
Depreciation Expense
2
2
2
2
2
1
2
5
6
3
4
4
3
3
Net Income, GAAP
8
11
7
6
2
6
7
12
13
3
3
3
10
6
Effective Tax Rate (%)
31.79
31.65
33.12
29.69
44.74
39.66
19.51
21.23
25.17
33.49
36.48
32.48
19.91
14.99
Profit Margin (%)
3.65
5.32
3.74
2.96
0.81
2.84
3.29
4.96
5.86
1.51
1.19
1.47
4.29
2.94
Working Capital
25
17
5
12
12
15
17
19
23
21
25
15
24
19
LT Debt
- -
25
9
7
5
3
- -
- -
16
13
12
12
10
8
Total Equity
34
4
3
11
15
22
27
33
37
32
35
26
35
33
Return on Invested Capital (%)
25.55
37.68
31.27
38.85
10.15
23.51
26.22
35.71
27.74
9.39
5.47
6.39
21.57
12.31
Return on Capital (%)
-9.93
-17.19
-10.46
-8.72
-1.94
-6.13
-7.85
-12.22
-15.52
-3.99
-3.03
-3.26
-10.45
-6.23
Return on Common Equity (%)
- -
10,208.97
12,284.48
- -
- -
76,813.33
742,900
1,154,900
1,289,400
312,000
254,000
293,700
980,500
- -

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
9
9
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
120
77
54

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
45
39
39
Cash, Cash Equivalents & STI
13
10
12
Accounts Receivable, Net
2
2
2
Inventories
21
19
18
Total Current Liabilities
19
19
20
Payables & Accruals
17
17
18
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
36.85%
2.91%
33.28%
Free Cash Flow
14.19%
12.02%
5.58%
Net Income, GAAP
42.14%
33.35%
233.84%
Sales/Revenue/Turnover
2.09%
-0.07%
14.17%
Total Cash Common Dividend
- -
- -
-70.22%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
51
52
48
49
200
2025
47
68
58
55
229
2026
48
49
44
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
-0.05
0.13
- -
0.24
2025
0.15
0.21
0.28
0.16
- -
2026
0.17
0.02
0.11
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.44
0.04
0.04
- -
0.56
2025
0.04
0.04
0.04
0.05
- -
2026
0.05
0.05
0.05
- -
- -

Company Description

APIChatGPT
CEO
Michael A. Beindorff
Full Time Employees
238
Sector
Consumer Defensive
Industry
Packaged Foods
Address
3300 North Triumph Boulevard Lehi UT United States of America 84043
IPO Date
Apr 7, 1994
Business
LifeVantage Corporation (Nasdaq: LFVN), founded in 2003 and headquartered in Lehi, Utah, engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators and related health and wellness products through a direct sales model with independent distributors. The company offers a portfolio of scientifically validated products including the flagship Protandim family (Nrf2 Synergizer and NRF1 Synergizer) for reducing oxidative stress and enhancing cellular energy; TrueScience anti-aging skin and hair care products such as liquid collagen, facial cleansers, eye creams, moisturizers, hand creams, shampoos, conditioners, and scalp serums; the MindBody GLP-1 System and PhysIQ weight management system featuring supplements, meal replacements, and lifestyle guidance; AXIO nootropic energy drink mixes; Petandim pet supplements for dogs; activation-supporting nutrients like Omega and D3+; and the Rise AM & Reset PM System. It operates in the Americas (United States, Canada, Mexico), Asia/Pacific (Japan, Hong Kong, Australia, Thailand, Philippines, Taiwan, Singapore, New Zealand), and Europe (United Kingdom, Netherlands, Germany, Austria, Spain, Ireland, Belgium). In September 2025, LifeVantage announced the acquisition of LoveBiome's key operating assets, a direct sales company focused on microbiome health solutions including the P84 product, expected to close by mid-October 2025, enhance revenue growth, and be accretive to adjusted EPS and EBITDA in the first year while expanding its consultant network and gut health offerings.

Company News

APIChatGPT
  • Do Options Traders Know Something About LifeVantage Stock We Don't?

  • LifeVantage Corporation (LFVN) Q3 2026 Earnings Call Transcript

  • Lifevantage (LFVN) Q3 Earnings and Revenues Miss Estimates

  • LifeVantage Declares Quarterly Dividend

  • LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026

  • Strength Seen in Lifevantage (LFVN): Can Its 8.5% Jump Turn into More Strength?

  • Lifevantage (NASDAQ:LFVN) Share Price Crosses Below 200-Day Moving Average – What’s Next?

  • LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026

  • LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack

  • LifeVantage Inspires with ‘Breakthrough' Announcements at 2026 Momentum Academy in Las Vegas

  • LifeVantage Appointing Terrence Moorehead as Chief Executive Officer

  • Lifevantage (NASDAQ:LFVN) Shares Pass Below Two Hundred Day Moving Average – Here’s What Happened

  • LifeVantage to Participate in Water Tower Research Insights Conference on Wednesday, April 15, 2026

  • LifeVantage Announces Expansion of its European Footprint with Market Opening in Portugal

  • LifeVantage to Participate in the Sidoti Small Cap Conference

  • Lifevantage (NASDAQ:LFVN) and Lancer Orthodontics (OTCMKTS:LANZ) Head to Head Analysis

  • Lifevantage Q2 Earnings Call Highlights

  • LifeVantage Corporation (LFVN) Q2 2026 Earnings Call Transcript

  • Lifevantage (LFVN) Q2 Earnings and Revenues Lag Estimates

  • LifeVantage Declares Quarterly Dividend